GLG Partners’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

GLG Partners’s Portfolio CYNA Stock Details CYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-375,000	Closed	-$15.1M	–	525
2016 Q3	$15.1M	Buy	+375,000	New	+$9.26M	0.46%	54

GLG Partners's CYNA Position: Q4 2016 in Review

GLG Partners sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 375,000 shares — an estimated $15.1M sold.

GLG Partners first reported a position in CYNA in Q3 2016 and held it in 1 quarter. The position peaked at $15.1M in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

GLG Partners reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
GLG Partners sold 375,000 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $15.1M.
GLG Partners first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2016 and held it in 1 quarter.
GLG Partners's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $15.1M in Q3 2016.
0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on GLG Partners's 13F filing for Q4 2016, filed 14 Feb 2017.